A Study of MZE782 in Adults With PKU (NCT07694440)
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, and Efficacy of MZE782 in Adults With Phenylketonuria (PKU)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).
Who can join: Review the eligibility criteria below.
Location: UCSF Benioff Children's Hospital Oakland — Oakland, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- UCSF Benioff Children's Hospital Oakland — Oakland, California
- Stanford University Clinical and Translational Research Unit — Palo Alto, California
- Indiana University School of Medicine — Indianapolis, Indiana
- University of Kentucky Medical Center — Lexington, Kentucky
- Clinic for Special Children — Gordonville, Pennsylvania
- University of Tennessee Health Science Center Le Bonheur Children's Hospital — Memphis, Tennessee
📞 Contact the Study Coordinator
Phone: (650) 850-5075
Email: medicalinfo@mazetx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Phenylketonuria (PKU)
- Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria — Phoenix, Arizona
- AAV Gene Therapy Study for Subjects with PKU — Tampa, Florida
- A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) — Aurora, Colorado
- A Long-Term Study of JNT-517 in Participants With Phenylketonuria — Gainesville, Florida
- A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade) — Aurora, Colorado
Explore by condition: All Phenylketonuria (PKU) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.